Why is Sun Pharma.Inds. falling/rising?

As of 28-Aug, Sun Pharmaceutical Industries Ltd is experiencing a decline in its stock price, currently at Rs 1,586.25, down by Rs 14.2 or 0.89%. The stock has been under pressure, having fallen for the last two days with a total decline of 4.25%. It is trading close to its 52-week low, just 1.97% away from Rs 1,555. Additionally, the stock is performing below its moving averages across various time frames, indicating a bearish trend. Despite these challenges, there has been a notable increase in investor participation, with delivery volume rising by 87.65% compared to the five-day average. The company maintains strong long-term fundamentals, including low debt and healthy growth in net sales and operating profit, which could support its price in the long run.
In the broader market context, Sun Pharma's recent performance has been weaker than the benchmark Sensex, with a one-week return of -3.26% compared to the Sensex's -2.34%. Over the past month, the stock has declined by 6.42%, while the Sensex has only dropped by 1.00%. This underperformance is further highlighted by the year-to-date return of -15.83% for Sun Pharma, contrasting sharply with the Sensex's positive return of 2.48%. The high institutional holdings at 36.75% suggest that informed investors are backing the company, which may provide some stability, but the current market sentiment appears to be negative, contributing to the stock's recent decline.